Chemistry:2F-Viminol
From HandWiki
Short description: Chemical compound
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C21H31FN2O |
| Molar mass | 346.490 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
2F-Viminol is a pyrrole derived opioid analgesic drug, which was originally developed by a team at the drug company Zambon in the 1960s. It is around twice as potent as the parent compound viminol, though unlike viminol, 2F-viminol has never passed clinical trials or been approved for medical use. 2F-Viminol has been sold as a designer drug, first being identified in Sweden in 2019.[1] It is one of a number of structurally atypical opioid agonists to have appeared on the designer drug grey-market since broad controls over fentanyl analogues were introduced in China in 2015.[2] It was made illegal in Sweden in August 2019 and in Latvia in November 2019.[3]
See also
References
- ↑ "Ordinance banning certain products that are harmful to health". Swedish Code of Statutes. 4 July 2019. https://ec.europa.eu/growth/tools-databases/tris/en/index.cfm/search/?trisaction=search.detail&year=2019&num=316&dLang=EN. "This Ordinance enters into force on 6 August 2019"
- ↑ "Control of fentanyl-related substances in China". The Lancet. Psychiatry 6 (7): e15. July 2019. doi:10.1016/S2215-0366(19)30218-4. PMID 31230685.
- ↑ "SPKC nosaka aizliegumu vielām 2F-viminol, furanyl UF – 17 un to saturošiem izstrādājumiem" (in Latvian). Slimību profilakses un kontroles centrs (Center for Disease Prevention and Control). 6 November 2019. https://www.spkc.gov.lv/lv/jaunums/spkc-nosaka-aizliegumu-vielam-2f-viminol-furanyl-uf-17-un-saturosiem-izstradajumiem-0.
 |  |
